Teresa Guida
About
In The Last Decade
Teresa Guida
18 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 858
- Oncology 772
- Endocrinology, Diabetes and Metabolism 653
- Pulmonary and Respiratory Medicine 327
- Pathology and Forensic Medicine 232
Countries citing papers authored by Teresa Guida
This map shows the geographic impact of Teresa Guida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Guida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Guida more than expected).
Fields of papers citing papers by Teresa Guida
This network shows the impact of papers produced by Teresa Guida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Guida. The network helps show where Teresa Guida may publish in the future.
Co-authorship network of co-authors of Teresa Guida
This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Guida. A scholar is included among the top collaborators of Teresa Guida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Guida. Teresa Guida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 4 | |
| 3 | 56 | |
| 4 | 45 | |
| 5 | 9 | |
| 6 | 17 | |
| 7 | 35 | |
| 8 | 2 | |
| 9 | 21 | |
| 10 | 61 | |
| 11 | 394 | |
| 12 | 35 | |
| 13 | 199 | |
| 14 | 96 | |
| 15 | Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomas. | 1 |
| 16 | ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases. | 481 |
| 17 | The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. | 118 |
| 18 | 244 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.